Sort
40,608 grants matching “prostate cancer”
Enhanced imaging and treatment of aggressive subtypes of prostate cancer
$428,295Martin G Pomper · Ut Southwestern Medical Center · R01 · FY2025 · CA
Personal Patient Profile-Prostate (P4) Randomized, Multi-site Trial
$428,276Donna L. Berry · University Of Washington · R01 · FY2007 · NR
Tumor Detection and Classification using QUS Technology's Structure Function
$428,275William D. O'Brien · University Of Illinois At Urbana-Champaign · R01 · FY2024 · CA
Molecular Targets for Cancer Detection and Treatment
$428,230William George Nelson · Johns Hopkins University · T32 · FY2010 · CA
SIMULTANEOUS LIGAND-DIRECTED CYTOTOXIC TOXIN AND ENDOSOME DISRUPTOR DELIVERY TO ABLATE PROSTATE CANCER
$428,202University Of Georgia Research Foundation, Inc. · · FY2017 · Department of the Army
Ultrasound Molecular Imaging to Assess Therapeutic Response
$428,190Mark Andrew Borden · University Of Colorado · R01 · FY2016 · CA
KanSurvive: Testing a model for improving cancer survivorship care in rural practice
$428,180Jennifer Rose Klemp · University Of Kansas Medical Center · R01 · FY2019 · CA
Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer
$428,151Shivendra Singh · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Epigenetic and microenvironmental regulation of dormant disseminated cancer
$428,136Julio A Aguirre-Ghiso · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA
Defining Molecular Determinants of Lineage Plasticity as a Mechanism of Treatment Resistance in Prostate Cancer
$428,090David S. Rickman · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA
Defining Molecular Determinants of Lineage Plasticity as a Mechanism of Treatment Resistance in Prostate Cancer
$428,090David S. Rickman · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
AKT-independent Pathways of Phosphoinositide 3-kinase dependent transformation
$428,015Charles L Sawyers · Beth Israel Deaconess Medical Center · P01 · FY2009 · CA
Integrated Translational Genoproteomics Center at Washington University
$428,007David G Mutch · Washington University · U10 · FY2016 · CA
Investigating lineage plasticity in castration-resistant prostate cancer
$427,889Michael M. Shen · Columbia University Health Sciences · R01 · FY2020 · CA
Investigating lineage plasticity in castration-resistant prostate cancer
$427,889Michael M. Shen · Columbia University Health Sciences · R01 · FY2021 · CA
Ponce School of Medicine - Moffitt Cancer Center Partnership
$427,841Warren Jackson Pledger · H. Lee Moffitt Cancer Ctr & Res Inst · U56 · FY2006 · CA
SCOTTSDALE COMMUNITY CLINICAL ONCOLOGY PROGRAM
$427,807Mayo Clinic Coll Of Med, Mayo Clinic Az · U10 · FY2000 · CA
PROTAC Targeting of Tip60 in Syngeneic Cancer Models Using Cereblon Knock-in Mice
$427,654Wayne William Hancock · Children'S Hosp Of Philadelphia · R01 · FY2020 · CA
ErbB receptor homo- and hetero-dimerization
$427,626Mark A. Lemmon · University Of Pennsylvania · R01 · FY2009 · CA
miRNA Profiling in Fixed Cancer Samples
$427,526Anna Schwarzbach · Ambion Diagnostics, Inc. · R44 · FY2009 · CA
Targeting convergent oncogenic signaling during AR inhibition to overcome metastasis and immune evasion in prostate cancer
$427,516Andrew J Armstrong · Duke University · R01 · FY2019 · CA
Development of Computer Aided Design of Helical Arylamide Foldamer Receptors for Selective Carbohydrate Recognition
$427,500Vojislava Pophristic · University Of The Sciences Philadelphia · R15 · FY2016 · GM
Immunogenic sugar moieties of prostate cancers
$427,463Denong Wang · Sri International · U01 · FY2011 · CA
The Role of Collagen and its Signaling Mechanisms in Glioma Progression and Invasion.
$427,257Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2025 · NS
Administrative Core
$427,245Arul M Chinnaiyan · University Of Michigan At Ann Arbor · U2C · FY2025 · CA